China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of targeted biological agents in the treatment of myasthenia gravis: A single-center retrospective study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134163
Registration Time: 2026/10/11
Type: Observational study
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=293895
Published by HT Digital Content Services with permission from Health Daily Digest....